Skip to main content
Clinical Trials/NCT04614090
NCT04614090CompletedNot Applicable

Is Fast Reversal and Early Surgery (Within 24 h) in Patients on Warfarin Medication With Trochanteric Hip Fractures Safe: A Case-control Study

Karolinska Institutet1 site in 1 country198 target enrollmentStarted: October 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
198
Locations
1
Primary Endpoint
Transfusion rates

Study Overview

Brief Summary

A retrospective case-control study. To evaluate if early surgery within 24hours of troch or subtrochanteric hip fractures using intramedullary nailing is safe in patients on warfarin treatment after fast reversal of the warfarin effect

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Pathological fracture
  • Late presentation to the hospital
  • Other injuries

Outcomes

Primary Outcomes

Transfusion rates

Time Frame: 2-4 days after the surgery

Transfusion rate (n)

adverse events

Time Frame: Immediately after the surgery

Number of patients with a myocardial infarction, stroke, pulmonary embolism, deep venous thrombosis, sepsis, pneumonia, urinary tract infection, pressure ulcer, or any adverse events.

mortality

Time Frame: 1 year after the surgery

The number of deaths

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Leif Mattisson

Senior Consultant Orthopaedic Surgeon MD.,Ph.D.

Karolinska Institutet

Study Sites (1)

Loading locations...

Similar Trials